| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000268670.1 |
Tanespimycin |
Esophageal cancer |
0.025832044 |
Resistant |
| ENSG00000268670.1 |
Tanespimycin |
Brain lower grade glioma |
0.043658514 |
Resistant |
| ENSG00000268670.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.026037598 |
Resistant |
| ENSG00000268670.1 |
Tanespimycin |
Skin cutaneous melanoma |
0.024237126 |
Resistant |
